Eli Lilly, Takeda Win Dismissal Of Ark. Taxpayer Actos Suit

A Louisiana federal judge on Thursday threw out a proposed class action alleging that Takeda Pharmaceutical Co. and Eli Lilly & Co. ripped off taxpayers by hiding the risks of their diabetes drug Actos, after the Arkansas Supreme Court ruled the drug was properly prescribed by doctors. In a two-page order granting the defendant’s motion to dismiss for failure to …

Takeda, Lilly Say Prejudice Infected $9B Actos Verdict

Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. argued Friday that the sheer size of the $9 billion punitive damages award they suffered in the bellwether personal injury trial over the diabetes drug Actos demonstrates the jury was inflamed by “passion and prejudice,” saying its verdict should be overturned. Reported as the seventh-largest punitive damages award in U.S. history, the April …

ACTOS UPDATE: (1) Eli Lilly Ducks Perjury Sanctions and (2) Blue Cross Sues Takeda & Eli Lilly

(1) Eli Lilly Ducks Perjury Sanctions In Actos Trial A federal judge on Wednesday declined to sanction Eli Lilly & Co. or subject a former executive to criminal investigation for zig-zagging on the stand during a bellwether trial alleging the diabetes drug Actos caused bladder cancer, saying the questionable testimony hadn’t stopped the plaintiffs from winning a $9 billion verdict. …